ROBERT A INGRAM Insider Trading $NOVN Novan, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT A INGRAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT A INGRAM. ROBERT A INGRAM is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in CREE INC ($CREE) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and Director in Edwards Lifesciences Corp ($EW) and Director in Novan, Inc. ($NOVN) and Director in Black Diamond Therapeutics, Inc. ($BDTX).
ROBERT A INGRAM in Novan, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 169,777 shares
Current Value: $690,992
Latest Transaction: Jul 30 2020
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT A INGRAM in Novan, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BVF, BCRX, BDTX, CREE, EW, NOVN, REGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2020 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 0.78 | 20,000 | 15,600 | 20,000 | |
| Jul 30 2020 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 0.78 | 20,000 | 15,600 | 20,000 | |
| Aug 02 2019 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 2.63 | 20,000 | 52,600 | 20,000 | |
| May 23 2019 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 2.21 | 50,000 | 110,500 | 169,777 | 119.8 K to 169.8 K (+41.74 %) |
| Oct 01 2018 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 2.84 | 50,000 | 142,000 | 119,777 | 69.8 K to 119.8 K (+71.66 %) |
| Jun 07 2018 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 3.08 | 20,000 | 61,600 | 20,000 | |
| Aug 29 2017 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 4.70 | 8,465 | 39,786 | 69,777 | 61.3 K to 69.8 K (+13.81 %) |
| Aug 29 2017 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | P | 4.25 | 3,535 | 15,024 | 61,312 | 57.8 K to 61.3 K (+6.12 %) |
| Jun 07 2017 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 4.64 | 34,014 | 157,825 | 34,014 | |
| Sep 28 2016 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | C | 0.00 | 27,777 | 0 | 0 | |
| Sep 28 2016 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Buy | C | 0.00 | 27,777 | 0 | 57,777 | 30 K to 57.8 K (+92.59 %) |
| Sep 22 2016 | NOVN | Novan, Inc. | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 11.00 | 14,484 | 159,324 | 14,484 |
Page: 1